EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications

Tomás Cerdó iD, Laurel Woodridge, Sagrario Corrales, Juan Rafael Muñoz-Castañeda, Ana Isabel Torralbo, Anisur Rahman iD, Filipa Farinha, Rafaela Ortega Castro iD, Pedro Segui, Ismael Sanchez-Pareja, Laura Muñoz-Barrera, Christian Merlo und 11 weitere

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Tomás Cerdó und 22 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Reina Sofía, University of Córdoba, Cordoba, Spain. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Cardiovascular Diseases, Lupus Nephritis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic lupus erythematosus (SLE) shows clinical and molecular heterogeneity, and cardiovascular (CV) complications and lupus nephritis (LN) remain leading causes of morbidity and mortality. This study investigated whether omic profiling can reveal molecular endotypes linked to these outcomes.

Methods

Serum from 199 patients with SLE underwent proximity extension assay–based proteomics and targeted nuclear magnetic resonance metabolomics. Unsupervised clustering was performed on proteomic data, followed by integrative multiomic factor analysis, logistic regression, and machine learning models. Cohorts with SLE from the University College London, a subset with expanded Olink Reveal panel and untargeted metabolomics, and in vitro (human umbilical vein endothelial cell and HK2) and ex vivo (rat kidneys) models exposed to patient sera were used for validation and mechanistic exploration.

Results

Proteomic clustering identified two molecular subgroups (cluster 1 and cluster 2). Compared with cluster 2, cluster 1 showed damage burden and increased rates of LN (1.8‐fold), hypertension (3‐fold), dyslipidemia (2‐fold), obesity (8‐fold), and abnormal C‐reactive protein/erythrocyte sedimentation rate (4‐fold), consistent with CV risk. A total of 47 inflammatory and organ‐damage proteins and multiple metabolites were increased in cluster 1. Neural network models based on metabolites and clinical variables discriminated clusters (area under the curve = 0.77), highlighting citrate and lipoproteins as key features. Multiomic analyses and external cohorts confirmed reproducibility and enrichment in pathways related to leukocyte trafficking, endothelial stress, and nephritis. In vitro, serum from patients with SLE induced NF‐κB activation in rat kidneys compared with controls, supporting a proinflammatory effect.

Conclusion

Multiomic profiling delineates molecular endotypes in SLE, integrating immune, vascular, and metabolic pathways associated with CV risk and LN, supporting their potential for precision risk stratification. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicCardiovascular DiseasesLupus NephritisHumansAnimalsFemaleMultiomicsProteomicsRatsAdultMetabolomicsMaleHuman Umbilical Vein Endothelial CellsMiddle AgedCluster AnalysisObesityKidneyHypertensionClustering Algorithms

Autor:innen und Institutionen

  • Instituto Maimónides de Investigación Biomédica de Córdoba, Hospital Reina Sofía, University of Córdoba, Cordoba, Spain.
  • Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom.
  • Center for Genomics and Oncological Research, Granada, Spain.
  • Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Cell Biology, Immunology and Physiology, Agrifood Campus of International Excellence, University of Córdoba, Cordoba, Spain.

ORCID-Profile: Tomás Cerdó, Anisur Rahman, Rafaela Ortega Castro, Nuria Barbarroja Puerto, Alejandro Escudero-Contreras, Carlos Perez-Sanchez, Elizabeth C Jury, Chary Lopez-Pedrera

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Cerdó, T., Woodridge, L., Corrales, S., Muñoz-Castañeda, J. R., Torralbo, A. I., Rahman, A., Farinha, F., Castro, R. O., Segui, P., Sanchez-Pareja, I., Muñoz-Barrera, L., Merlo, C., Ruiz-Vilchez, D., Ábalos-Aguilera, M. C., Font, P., Puerto, N. B., PRECISESADS Clinical Consortium, Alarcón-Riquelme, M., Escudero-Contreras, A., …, & Lopez-Pedrera, C. (2026). Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications. Arthritis & Rheumatology. https://doi.org/10.1002/art.70127

Vancouver

Cerdó T, Woodridge L, Corrales S, Muñoz-Castañeda JR, Torralbo AI, Rahman A, et al. Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications. Arthritis & Rheumatology. 2026. doi:10.1002/art.70127

BibTeX
@article{Cerd2026,
  author = {Cerdó, Tomás and Woodridge, Laurel and Corrales, Sagrario and Muñoz-Castañeda, Juan Rafael and Torralbo, Ana Isabel and Rahman, Anisur and Farinha, Filipa and Castro, Rafaela Ortega and Segui, Pedro and Sanchez-Pareja, Ismael and Muñoz-Barrera, Laura and Merlo, Christian and Ruiz-Vilchez, Desiree and Ábalos-Aguilera, M Carmen and Font, Pilar and Puerto, Nuria Barbarroja and PRECISESADS Clinical Consortium, PRECISESADS Clinical Consortium and Alarcón-Riquelme, Marta and Escudero-Contreras, Alejandro and Aguirre-Zamorano, M Ángeles and Perez-Sanchez, Carlos and Jury, Elizabeth C and Lopez-Pedrera, Chary},
  title = {Unveiling Endotypes in Systemic Lupus Erythematosus Through Multiomic Analysis: Insights Into Cardiovascular and Renal Complications},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70127}
}
Kostenlos starten →